Within the AstraZeneca Cell Therapy Unit (CTU), our ambition is to realize the full potential of cell therapy for people living with cancer, immune-mediated and rare diseases around the world. This unit has responsibility for the value chain from discovery through to late-stage development and commercialization. We are rapidly progressing a broad pipeline of cell therapies in collaboration with AstraZeneca’s Therapeutic Area Units. The Executive Director, Global Product Leader (GPL – Solid Tumor Franchise) - will have overall leadership and accountability for global, cross-functional teams delivering discovery and clinical studies with embedded translational medicine research to establish proof-of-concept data enabling registrational investment strategies. This individual will be accountable for the strategic leadership and execution of clinical development and commercialization plans, aligning prioritization across oncology research units to advance the solid tumor-directed cell therapy pipeline. You will have oncology clinical drug development experience, demonstrated leadership, and be able to critically evaluate the science, clinical data and competitive landscape that underlies each program. You will be able to effectively communicate across a broad range of audiences and have the ability to clearly articulate project-specific strategies and deliverables as it relates to the overall AZ Oncology and Cell Therapy Unit visions.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive